Clinical Laboratory Services Market by End-user, Application, and Geography - Forecast and Analysis 2023-2027

Published: Apr 2023 Pages: 178 SKU: IRTNTR46517

The clinical laboratory services market size is estimated to grow at a CAGR of 10.25% between 2022 and 2027. The market size is forecast to increase by USD 147.44 billion. The growth of the market depends on several factors, including growth in the geriatric population, increasing prevalence of chronic diseases, and the advent of automation and laboratory robotics. 

This clinical laboratory services market report extensively covers market segmentation by end-user (hospital-based laboratories, stand-alone laboratories, and clinic-based laboratories), application (bioanalytical and lab chemistry, toxicology testing, cell and gene therapy, preclinical and clinical trial, and others), and geography (North America, Europe, Asia, and Rest of World (ROW). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the size of the Clinical Laboratory Services Market During the Forecast Period?

To learn more about this report, View Report Sample

Clinical Laboratory Services Market: Key Drivers, Trends, Challenges, and Customer Landscape

The advent of automation and laboratory robotics is notably driving the market growth, although factors such as the lack of skilled professionals may impede the market growth. Our researchers analyzed the data with 2022 as the base year and the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Clinical Laboratory Services Market Driver

The advent of automation and laboratory robotics is notably driving the market growth. Laboratory automation is a result of the development of laboratory robotics. Diagnostic and testing procedures are now more effective and efficient due to robotics. This is so that large-scale biorepositories, combinatorial chemistry, automated clinical and analytical testing, and high-throughput screening can all be done in automated laboratories. Clinical laboratories that are fully automated can offer high-quality results at reasonable prices. Advanced automated clinical laboratories can boost output, enhance the quality of experimental data, and shorten cycle times for laboratory processes.

Automation is also occurring in microbiology. Fully automated tools like DNA extractors and immunostainer platforms for anatomic pathology will propel the market for molecular diagnostics. Anatomic pathology and some molecular diagnostics procedures take a long time, cost a lot of money, and only work 82% of the time. However, automated tools can cut costs and time while increasing productivity by up to 95%. Clinical laboratories can manage the transfer of specimens between disciplines and produce results quickly with the aid of fully automated instruments. Thus, such factors will drive the growth of the global market during the forecast period.

Significant Clinical Laboratory Services Market Trends

The increasing adoption of preventive healthcare is an emerging trend influencing the market growth. The adoption of preventive healthcare is rising as a result of the rising prevalence of chronic diseases. Instead of treating diseases, preventive healthcare focuses on preventing them. It is possible to prevent disease due to routine medical examinations. The use of routine medical tests is also expanding. The main goal of routine checkups is to stop illnesses in their tracks. Depending on the patient's age and gender, doctors may advise routine medical tests. For instance, breast cancer is more likely to strike women between the ages of 38 and 42. As a result, it is advised that they undergo routine mammogram screening, which raises the demand for clinical laboratory services.

Additionally, more diseases are becoming contagious. Due to poor eating practices, people are more susceptible to bacterial and viral infections, which is driving the demand for tests for tropical diseases like malaria and TB. Furthermore, companies, particularly in nations like the US, also provide insurance for preventive healthcare. These programs cover disease prevention. Therefore, the increasing adoption of preventive healthcare will drive the growth of the global market during the forecast period.

Major Clinical Laboratory Services Market Challenge

The lack of skilled professionals is a major challenge impeding the market growth. Professionals in the field of clinical laboratory medicine are skilled, certified individuals who have received training in both its theoretical and applied components. These include molecular pathology, chemistry, microbiology, immunology, and blood banking. Clinical laboratory professionals can work as staff technologists, research technologists, managers, supervisors, or educators, among other positions. Clinical laboratory professionals make between 60% and 70% of all medical decisions involving hospital admissions, discharge, diagnosis, and treatment.

The majority of lab technicians and medical professionals are uninformed about technology's advantages. There is a lack of skilled personnel who can operate technologically cutting-edge diagnostic equipment. The likelihood of a false diagnosis rises due to a lack of expertise. As a result, it's crucial to train staff on how to use essential diagnostic tools. As the market is very competitive, a precise diagnosis is crucial. Thus, the lack of skilled professionals could affect the growth of the global market during the forecast period.

Key Clinical Laboratory Services Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Clinical Laboratory Services Market Customer Landscape

Who are the Major Clinical Laboratory Services Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

ARUP Laboratories - The company provides laboratory testing services for hospitals and health centers to serve the diagnostic needs of patients. The key offerings of the company include a broad test menu to support clinical trials related to molecular genetics, infectious disease, pain management, and others.

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

  • Abbott Laboratories
  • AP Moller Holding AS
  • Bio Rad Laboratories Inc.
  • Cerba HealthCare
  • Charles River Laboratories International Inc.
  • Enzo Clinical Labs
  • Eurofins Scientific SE
  • Fresenius Medical Care AG and Co. KGaA
  • Genova Diagnostics Inc.
  • HU Group Holdings Inc.
  • Illumina Inc.
  • Laboratory Corp. of America Holdings
  • NeoGenomics Laboratories Inc.
  • OPKO Health Inc.
  • QIAGEN NV

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Clinical Laboratory Services Market?

The market share growth by the hospital-based laboratories segment will be significant during the forecast period. Due to collaboration, hospital-based laboratories get references from big hospitals. Hospital-based laboratories dominated a major share of the market in 2020. To enhance operations, clinical laboratories collaborate with hospital laboratories. For instance, the San Francisco General Hospital and the UCSF Medical Centre collaborated.

Get a glance at the market contribution of various segments View the PDF Sample

The hospital-based laboratories segment was valued at USD 75.75 billion in 2017 and continued to grow until 2021. Rapid diagnostics using cutting-edge technology gives results quickly. However, these tests need expensive apparatus. Real-time polymerase chain reaction (PCR) and peptide nucleic acid fluorescent in situ hybridization (PNA-FISH) tests are two examples of tests that hospitals outsource to cut costs. These tests shorten hospital stays and offer early, targeted therapy. Due to these benefits, HCPs are more likely to recommend such tests to clinical laboratories. Clinical laboratories benefit from increased customer traffic due to partnerships with hospitals. From straightforward educational and consulting support to high-end solutions, clinical laboratories provide a wide range of laboratory solutions. Along with these additional services, clinical laboratories also offer hospital outreach testing to increase physician-hospital connectivity, within-network sample transport, laboratory efficiency audits, quality improvement programs, staffing, information technology (IT) products, laboratory management, and support for couriers for operational benchmarking. Such collaborations are beneficial to both hospitals and clinical laboratories, which will drive the adoption of hospital-based clinical laboratories during the forecast period.

Which are the Key Regions for the Clinical Laboratory Services Market?

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The market in North America is evolving. This is mainly because chronic diseases like diabetes and cardiovascular disease are becoming more common. The US dominates the market in the region. This is a result of a widespread understanding of disease prevention and the advancement of quick diagnostics. The development of time- and money-saving diagnostic procedures is the main focus of vendors in the region. In the US, in vitro tests are also becoming more popular. This is caused by the rise in chronic diseases and diseases related to lifestyle. The emergence of laboratory automation, the move toward rapid diagnostic tests, and the rise in US Food and Drug Administration (FDA) approvals of new diagnostics procedures, such as microbial tests and human genetic tests, are propelling the market's expansion in the region.

The market is expanding due to the rise in corporate wellness initiatives as well as travel and tourism. The US has a large number of businesses that include healthcare benefits in their corporate wellness initiatives, which boosts demand for clinical laboratory services. The market is also expanding as a result of the rising demand for clinical laboratory services from governmental organizations for procedures like visa approval. Moreover, the number of research initiatives in the US has increased. This is due to the high potential of regenerative medicines. Funding has also increased for institutions like the Biomedical Advanced Research and Development Authority (BARDA) and the National Institutes of Health (NIH). These groups support the advancement of clinical trials and the creation of fresh medications for various illnesses. Hence, all these factors will drive the growth of the market in the region during the forecast period.

The outbreak of the COVID-19 pandemic positively impacted the market in North America in 2020. The growing number of COVID-19 cases placed a significant strain on local healthcare facilities and services. Labs consistently increased their testing capacity to keep up with the rising demand for COVID-19 testing. Thus, it is expected that the market in the region will witness growth during the forecast period.

Segment Overview

The clinical laboratory services market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • End-user Outlook (USD Billion, 2017 - 2027)
    • Hospital-based laboratories
    • Stand-alone laboratories
    • Clinic-based laboratories
  • Application Outlook (USD Billion, 2017 - 2027)
    • Bioanalytical and lab chemistry
    • Toxicology testing
    • Cell and gene therapy
    • Preclinical and clinical trial
    • Others
  • Region Outlook (USD Billion, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
      • Others
    • Rest of World
      • Saudi Arabia
      • South Africa
      • Others

Parent Market Analysis

Technavio categorizes the global clinical laboratory services market as a part of the global life sciences tools and services market. The parent, global life sciences tools and services market covers products and companies engaged in research and development (R&D) of a variety of product categories, including capital equipment, instruments, accessories, and consumables that are used for R&D on pharmaceuticals and biotechnology products and laboratory diagnosis of various diseases. Our market research report has extensively covered external factors influencing the parent market growth during the forecast period.

Clinical Laboratory Services Market Scope

Report Coverage

Details

Page number

178

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 10.25%

Market growth 2023-2027

USD 147.44 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

8.91

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 38%

Key countries

US, UK, Germany, China, and Japan

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, AP Moller Holding AS, ARUP Laboratories, Bio Rad Laboratories Inc., Cerba HealthCare, Charles River Laboratories International Inc., Enzo Clinical Labs, Eurofins Scientific SE, Fresenius Medical Care AG and Co. KGaA, Genova Diagnostics Inc., HU Group Holdings Inc., Illumina Inc., Laboratory Corp. of America Holdings, NeoGenomics Laboratories Inc., OPKO Health Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Sonic Healthcare Ltd., and SYNLAB International GmbH

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. 

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View the PDF sample

What are the Key Data Covered in this Clinical Laboratory Services Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the clinical laboratory services market between 2023 and 2027
  • Precise estimation of the size of the clinical laboratory services market size and its contribution to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of clinical laboratory services market vendors

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global Clinical Laboratory services market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global Clinical Laboratory services market 2017 - 2021 ($ billion)
    • 4.2 End-user Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – End-user Segment 2017 - 2021 ($ billion)
    • 4.3 Application Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ billion)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Hospital-based laboratories - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Hospital-based laboratories - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 35: Data Table on Hospital-based laboratories - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 36: Chart on Hospital-based laboratories - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Hospital-based laboratories - Year-over-year growth 2022-2027 (%)
    • 6.4 Stand-alone laboratories - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Stand-alone laboratories - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 39: Data Table on Stand-alone laboratories - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 40: Chart on Stand-alone laboratories - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Stand-alone laboratories - Year-over-year growth 2022-2027 (%)
    • 6.5 Clinic-based laboratories - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Clinic-based laboratories - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 43: Data Table on Clinic-based laboratories - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 44: Chart on Clinic-based laboratories - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Clinic-based laboratories - Year-over-year growth 2022-2027 (%)
    • 6.6 Market opportunity by End-user
      • Exhibit 46: Market opportunity by End-user ($ billion)
      • Exhibit 47: Data Table on Market opportunity by End-user ($ billion)

    7 Market Segmentation by Application

    • 7.1 Market segments
      • Exhibit 48: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 49: Data Table on Application - Market share 2022-2027 (%)
    • 7.2 Comparison by Application
      • Exhibit 50: Chart on Comparison by Application
      • Exhibit 51: Data Table on Comparison by Application
    • 7.3 Bioanalytical and lab chemistry - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Bioanalytical and lab chemistry - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 53: Data Table on Bioanalytical and lab chemistry - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 54: Chart on Bioanalytical and lab chemistry - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Bioanalytical and lab chemistry - Year-over-year growth 2022-2027 (%)
    • 7.4 Toxicology testing - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Toxicology testing - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 57: Data Table on Toxicology testing - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 58: Chart on Toxicology testing - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Toxicology testing - Year-over-year growth 2022-2027 (%)
    • 7.5 Cell and gene therapy - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Cell and gene therapy - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 61: Data Table on Cell and gene therapy - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 62: Chart on Cell and gene therapy - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Cell and gene therapy - Year-over-year growth 2022-2027 (%)
    • 7.6 Preclinical and clinical trial - Market size and forecast 2022-2027
      • Exhibit 64: Chart on Preclinical and clinical trial - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 65: Data Table on Preclinical and clinical trial - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 66: Chart on Preclinical and clinical trial - Year-over-year growth 2022-2027 (%)
      • Exhibit 67: Data Table on Preclinical and clinical trial - Year-over-year growth 2022-2027 (%)
    • 7.7 Others - Market size and forecast 2022-2027
      • Exhibit 68: Chart on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 69: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 70: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.8 Market opportunity by Application
      • Exhibit 72: Market opportunity by Application ($ billion)
      • Exhibit 73: Data Table on Market opportunity by Application ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 75: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 76: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 77: Chart on Geographic comparison
      • Exhibit 78: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 UK - Market size and forecast 2022-2027
      • Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.9 China - Market size and forecast 2022-2027
      • Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.10 Germany - Market size and forecast 2022-2027
      • Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.11 Japan - Market size and forecast 2022-2027
      • Exhibit 111: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 112: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 113: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 114: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 115: Market opportunity by geography ($ billion)
      • Exhibit 116: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 117: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 119: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 120: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 121: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 122: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 123: Abbott Laboratories - Overview
              • Exhibit 124: Abbott Laboratories - Business segments
              • Exhibit 125: Abbott Laboratories - Key news
              • Exhibit 126: Abbott Laboratories - Key offerings
              • Exhibit 127: Abbott Laboratories - Segment focus
            • 12.4 ARUP Laboratories
              • Exhibit 128: ARUP Laboratories - Overview
              • Exhibit 129: ARUP Laboratories - Product / Service
              • Exhibit 130: ARUP Laboratories - Key offerings
            • 12.5 Bio Rad Laboratories Inc.
              • Exhibit 131: Bio Rad Laboratories Inc. - Overview
              • Exhibit 132: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 133: Bio Rad Laboratories Inc. - Key news
              • Exhibit 134: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 135: Bio Rad Laboratories Inc. - Segment focus
            • 12.6 Cerba HealthCare
              • Exhibit 136: Cerba HealthCare - Overview
              • Exhibit 137: Cerba HealthCare - Product / Service
              • Exhibit 138: Cerba HealthCare - Key offerings
            • 12.7 Charles River Laboratories International Inc.
              • Exhibit 139: Charles River Laboratories International Inc. - Overview
              • Exhibit 140: Charles River Laboratories International Inc. - Business segments
              • Exhibit 141: Charles River Laboratories International Inc. - Key news
              • Exhibit 142: Charles River Laboratories International Inc. - Key offerings
              • Exhibit 143: Charles River Laboratories International Inc. - Segment focus
            • 12.8 Eurofins Scientific SE
              • Exhibit 144: Eurofins Scientific SE - Overview
              • Exhibit 145: Eurofins Scientific SE - Business segments
              • Exhibit 146: Eurofins Scientific SE - Key news
              • Exhibit 147: Eurofins Scientific SE - Key offerings
              • Exhibit 148: Eurofins Scientific SE - Segment focus
            • 12.9 Fresenius Medical Care AG and Co. KGaA
              • Exhibit 149: Fresenius Medical Care AG and Co. KGaA - Overview
              • Exhibit 150: Fresenius Medical Care AG and Co. KGaA - Business segments
              • Exhibit 151: Fresenius Medical Care AG and Co. KGaA - Key news
              • Exhibit 152: Fresenius Medical Care AG and Co. KGaA - Key offerings
              • Exhibit 153: Fresenius Medical Care AG and Co. KGaA - Segment focus
            • 12.10 Illumina Inc.
              • Exhibit 154: Illumina Inc. - Overview
              • Exhibit 155: Illumina Inc. - Business segments
              • Exhibit 156: Illumina Inc. - Key news
              • Exhibit 157: Illumina Inc. - Key offerings
              • Exhibit 158: Illumina Inc. - Segment focus
            • 12.11 Laboratory Corp. of America Holdings
              • Exhibit 159: Laboratory Corp. of America Holdings - Overview
              • Exhibit 160: Laboratory Corp. of America Holdings - Business segments
              • Exhibit 161: Laboratory Corp. of America Holdings - Key news
              • Exhibit 162: Laboratory Corp. of America Holdings - Key offerings
              • Exhibit 163: Laboratory Corp. of America Holdings - Segment focus
            • 12.12 NeoGenomics Laboratories Inc.
              • Exhibit 164: NeoGenomics Laboratories Inc. - Overview
              • Exhibit 165: NeoGenomics Laboratories Inc. - Business segments
              • Exhibit 166: NeoGenomics Laboratories Inc. - Key news
              • Exhibit 167: NeoGenomics Laboratories Inc. - Key offerings
              • Exhibit 168: NeoGenomics Laboratories Inc. - Segment focus
            • 12.13 OPKO Health Inc.
              • Exhibit 169: OPKO Health Inc. - Overview
              • Exhibit 170: OPKO Health Inc. - Business segments
              • Exhibit 171: OPKO Health Inc. - Key offerings
              • Exhibit 172: OPKO Health Inc. - Segment focus
            • 12.14 QIAGEN NV
              • Exhibit 173: QIAGEN NV - Overview
              • Exhibit 174: QIAGEN NV - Product / Service
              • Exhibit 175: QIAGEN NV - Key news
              • Exhibit 176: QIAGEN NV - Key offerings
            • 12.15 Quest Diagnostics Inc.
              • Exhibit 177: Quest Diagnostics Inc. - Overview
              • Exhibit 178: Quest Diagnostics Inc. - Business segments
              • Exhibit 179: Quest Diagnostics Inc. - Key offerings
              • Exhibit 180: Quest Diagnostics Inc. - Segment focus
            • 12.16 Siemens AG
              • Exhibit 181: Siemens AG - Overview
              • Exhibit 182: Siemens AG - Business segments
              • Exhibit 183: Siemens AG - Key news
              • Exhibit 184: Siemens AG - Key offerings
              • Exhibit 185: Siemens AG - Segment focus
            • 12.17 Sonic Healthcare Ltd.
              • Exhibit 186: Sonic Healthcare Ltd. - Overview
              • Exhibit 187: Sonic Healthcare Ltd. - Business segments
              • Exhibit 188: Sonic Healthcare Ltd. - Key offerings
              • Exhibit 189: Sonic Healthcare Ltd. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 190: Inclusions checklist
                • Exhibit 191: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 192: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 193: Research methodology
                • Exhibit 194: Validation techniques employed for market sizing
                • Exhibit 195: Information sources
              • 13.5 List of abbreviations
                • Exhibit 196: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              clinical laboratory services market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis